Logo image of KIN2.DE

KINROSS GOLD CORP (KIN2.DE) Stock Fundamental Analysis

FRA:KIN2 - Deutsche Boerse Ag - CA4969024047 - Common Stock - Currency: EUR

12.735  -0.1 (-0.74%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to KIN2. KIN2 was compared to 38 industry peers in the Metals & Mining industry. KIN2 has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. KIN2 is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

KIN2 had positive earnings in the past year.
In the past year KIN2 had a positive cash flow from operations.
KIN2 had positive earnings in 4 of the past 5 years.
KIN2 had a positive operating cash flow in each of the past 5 years.
KIN2.DE Yearly Net Income VS EBIT VS OCF VS FCFKIN2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

1.2 Ratios

With an excellent Return On Assets value of 8.73%, KIN2 belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
With an excellent Return On Equity value of 13.83%, KIN2 belongs to the best of the industry, outperforming 81.58% of the companies in the same industry.
KIN2 has a Return On Invested Capital of 9.40%. This is amongst the best in the industry. KIN2 outperforms 81.58% of its industry peers.
The Average Return On Invested Capital over the past 3 years for KIN2 is in line with the industry average of 6.32%.
The 3 year average ROIC (6.23%) for KIN2 is below the current ROIC(9.40%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.73%
ROE 13.83%
ROIC 9.4%
ROA(3y)2.29%
ROA(5y)4.25%
ROE(3y)3.43%
ROE(5y)6.8%
ROIC(3y)6.23%
ROIC(5y)6.54%
KIN2.DE Yearly ROA, ROE, ROICKIN2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

KIN2 has a Profit Margin of 18.43%. This is amongst the best in the industry. KIN2 outperforms 84.21% of its industry peers.
KIN2's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 28.48%, KIN2 belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
In the last couple of years the Operating Margin of KIN2 has grown nicely.
Looking at the Gross Margin, with a value of 35.04%, KIN2 is in the better half of the industry, outperforming 63.16% of the companies in the same industry.
KIN2's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 28.48%
PM (TTM) 18.43%
GM 35.04%
OM growth 3Y9.12%
OM growth 5Y8.75%
PM growth 3Y45.92%
PM growth 5Y-2.15%
GM growth 3Y3.98%
GM growth 5Y4.42%
KIN2.DE Yearly Profit, Operating, Gross MarginsKIN2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KIN2 is still creating some value.
The number of shares outstanding for KIN2 remains at a similar level compared to 1 year ago.
The number of shares outstanding for KIN2 has been reduced compared to 5 years ago.
The debt/assets ratio for KIN2 has been reduced compared to a year ago.
KIN2.DE Yearly Shares OutstandingKIN2.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
KIN2.DE Yearly Total Debt VS Total AssetsKIN2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 2.65 indicates that KIN2 is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of KIN2 (2.65) is better than 76.32% of its industry peers.
The Debt to FCF ratio of KIN2 is 1.05, which is an excellent value as it means it would take KIN2, only 1.05 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.05, KIN2 belongs to the best of the industry, outperforming 97.37% of the companies in the same industry.
A Debt/Equity ratio of 0.18 indicates that KIN2 is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.18, KIN2 is in the better half of the industry, outperforming 68.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.05
Altman-Z 2.65
ROIC/WACC1.07
WACC8.8%
KIN2.DE Yearly LT Debt VS Equity VS FCFKIN2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.01 indicates that KIN2 has no problem at all paying its short term obligations.
KIN2 has a Current ratio of 2.01. This is in the better half of the industry: KIN2 outperforms 76.32% of its industry peers.
KIN2 has a Quick Ratio of 2.01. This is a bad value and indicates that KIN2 is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.83, KIN2 perfoms like the industry average, outperforming 44.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 0.83
KIN2.DE Yearly Current Assets VS Current LiabilitesKIN2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 54.20% over the past year.
Measured over the past years, KIN2 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.87% on average per year.
Looking at the last year, KIN2 shows a very strong growth in Revenue. The Revenue has grown by 21.44%.
The Revenue has been growing by 8.04% on average over the past years. This is quite good.
EPS 1Y (TTM)54.2%
EPS 3Y17.42%
EPS 5Y14.87%
EPS Q2Q%81.82%
Revenue 1Y (TTM)21.44%
Revenue growth 3Y11.35%
Revenue growth 5Y8.04%
Sales Q2Q%26.9%

3.2 Future

The Earnings Per Share is expected to decrease by -4.48% on average over the next years.
The Revenue is expected to decrease by -4.78% on average over the next years.
EPS Next Y40.71%
EPS Next 2Y20.9%
EPS Next 3Y14.28%
EPS Next 5Y-4.48%
Revenue Next Year13.21%
Revenue Next 2Y6.6%
Revenue Next 3Y5.46%
Revenue Next 5Y-4.78%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
KIN2.DE Yearly Revenue VS EstimatesKIN2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
KIN2.DE Yearly EPS VS EstimatesKIN2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4 0.6 0.8 1

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.23 indicates a rather expensive valuation of KIN2.
KIN2's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 28.98. KIN2 is valued slightly cheaper when compared to this.
KIN2 is valuated correctly with a Price/Forward Earnings ratio of 15.14.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KIN2 is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.38, KIN2 is valued a bit cheaper.
Industry RankSector Rank
PE 21.23
Fwd PE 15.14
KIN2.DE Price Earnings VS Forward Price EarningsKIN2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as KIN2.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of KIN2 indicates a rather cheap valuation: KIN2 is cheaper than 89.47% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13
EV/EBITDA 7.13
KIN2.DE Per share dataKIN2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KIN2 has an outstanding profitability rating, which may justify a higher PE ratio.
KIN2's earnings are expected to grow with 14.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.52
PEG (5Y)1.43
EPS Next 2Y20.9%
EPS Next 3Y14.28%

2

5. Dividend

5.1 Amount

KIN2 has a yearly dividend return of 0.80%, which is pretty low.
Compared to an average industry Dividend Yield of 3.75, KIN2 is paying slightly less dividend.
With a Dividend Yield of 0.80, KIN2 pays less dividend than the S&P500 average, which is at 2.46.
Industry RankSector Rank
Dividend Yield 0.8%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
KIN2.DE Yearly Dividends per shareKIN2.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 0.05 0.1 0.15

5.3 Sustainability

15.55% of the earnings are spent on dividend by KIN2. This is a low number and sustainable payout ratio.
DP15.55%
EPS Next 2Y20.9%
EPS Next 3Y14.28%
KIN2.DE Yearly Income VS Free CF VS DividendKIN2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
KIN2.DE Dividend Payout.KIN2.DE Dividend Payout, showing the Payout Ratio.KIN2.DE Dividend Payout.PayoutRetained Earnings

KINROSS GOLD CORP

FRA:KIN2 (4/29/2025, 7:00:00 PM)

12.735

-0.1 (-0.74%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)05-06 2025-05-06
Inst Owners68.64%
Inst Owner ChangeN/A
Ins Owners0.21%
Ins Owner ChangeN/A
Market Cap15.67B
Analysts80
Price Target14.43 (13.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.8%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP15.55%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.54%
Min EPS beat(2)-18.81%
Max EPS beat(2)25.89%
EPS beat(4)3
Avg EPS beat(4)16.49%
Min EPS beat(4)-18.81%
Max EPS beat(4)57.06%
EPS beat(8)7
Avg EPS beat(8)29.26%
EPS beat(12)8
Avg EPS beat(12)13.27%
EPS beat(16)10
Avg EPS beat(16)12.49%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.06%
PT rev (3m)16.41%
EPS NQ rev (1m)9.37%
EPS NQ rev (3m)5.71%
EPS NY rev (1m)17.53%
EPS NY rev (3m)11.63%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)4.98%
Revenue NY rev (3m)7.39%
Valuation
Industry RankSector Rank
PE 21.23
Fwd PE 15.14
P/S 3.46
P/FCF 13
P/OCF 7.28
P/B 2.6
P/tB 2.6
EV/EBITDA 7.13
EPS(TTM)0.6
EY4.71%
EPS(NY)0.84
Fwd EY6.61%
FCF(TTM)0.98
FCFY7.69%
OCF(TTM)1.75
OCFY13.73%
SpS3.68
BVpS4.9
TBVpS4.9
PEG (NY)0.52
PEG (5Y)1.43
Profitability
Industry RankSector Rank
ROA 8.73%
ROE 13.83%
ROCE 14.95%
ROIC 9.4%
ROICexc 10.02%
ROICexgc 10.02%
OM 28.48%
PM (TTM) 18.43%
GM 35.04%
FCFM 26.63%
ROA(3y)2.29%
ROA(5y)4.25%
ROE(3y)3.43%
ROE(5y)6.8%
ROIC(3y)6.23%
ROIC(5y)6.54%
ROICexc(3y)6.62%
ROICexc(5y)7.08%
ROICexgc(3y)6.62%
ROICexgc(5y)7.14%
ROCE(3y)9.92%
ROCE(5y)10.4%
ROICexcg growth 3Y20.62%
ROICexcg growth 5Y13.48%
ROICexc growth 3Y21.33%
ROICexc growth 5Y13.94%
OM growth 3Y9.12%
OM growth 5Y8.75%
PM growth 3Y45.92%
PM growth 5Y-2.15%
GM growth 3Y3.98%
GM growth 5Y4.42%
F-Score7
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.05
Debt/EBITDA 0.47
Cap/Depr 93.73%
Cap/Sales 20.89%
Interest Coverage 11.44
Cash Conversion 93.6%
Profit Quality 144.49%
Current Ratio 2.01
Quick Ratio 0.83
Altman-Z 2.65
F-Score7
WACC8.8%
ROIC/WACC1.07
Cap/Depr(3y)100.83%
Cap/Depr(5y)104.58%
Cap/Sales(3y)22.97%
Cap/Sales(5y)23.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.2%
EPS 3Y17.42%
EPS 5Y14.87%
EPS Q2Q%81.82%
EPS Next Y40.71%
EPS Next 2Y20.9%
EPS Next 3Y14.28%
EPS Next 5Y-4.48%
Revenue 1Y (TTM)21.44%
Revenue growth 3Y11.35%
Revenue growth 5Y8.04%
Sales Q2Q%26.9%
Revenue Next Year13.21%
Revenue Next 2Y6.6%
Revenue Next 3Y5.46%
Revenue Next 5Y-4.78%
EBIT growth 1Y74.49%
EBIT growth 3Y21.5%
EBIT growth 5Y17.5%
EBIT Next Year105.62%
EBIT Next 3Y25.1%
EBIT Next 5Y4.98%
FCF growth 1Y170.39%
FCF growth 3Y91.05%
FCF growth 5Y62.85%
OCF growth 1Y52.4%
OCF growth 3Y29.17%
OCF growth 5Y14.84%